<DOC>
	<DOCNO>NCT00451516</DOCNO>
	<brief_summary>SJW great evidence herbal medicine efficacy treat MDD . In treat anxiety , kava great evidence efficacy . As comorbidity MDD anxiety commonly occur , conceivable combination establish antidepressant agent SJW establish anxiolytic agent kava may effectively treat MDD present comorbid anxiety . It possible beneficial synergistic effect may also occur SJW kava , improve treatment outcome MDD comorbid anxiety , individual substance alone . Determination address study due limitation time resource . The determination strength SJW-kava combination ascertain compare similar trial use SJW kava mono-therapy address MDD GAD . The hypothesis combination SJW kava reduce MDD occur comorbid anxiety placebo .</brief_summary>
	<brief_title>St. John 's Wort And Kava In The Treatment Of Major Depressive Disorder With Comorbid Anxiety</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Anxiety Disorders</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<criteria>Inclusion criterion : Any person male female age 1865 present diagnosis unipolar depression confirm CIDI auto ( quantified BDI ) anxiety score DASS 8 i.e . mean ( quantify also BAI ) Exclusion criterion : Psychotic/ Bipolar illness Current &lt; 6 month significant suicidal ideation Diagnosed hepatobiliary disease/inflammation Current &lt; 6 month substance abuse disorder include alcohol Current &lt; 12 month use kava , St. John 's wort , Current &lt; 1 month synthetic antidepressant benzodiazepines Previous reaction kava St. John 's wort Medications maybe pharmacokinetically altered via St. John 's wort include : Amitriptyline anticoagulant e.g . phenprocoumon , warfarin , Antifugals e.g . voriconazole , Antihistamines e.g . fexofenadine , Benzodiazepines e.g . alprazolam , Chemotherapeutics e.g . irinotecan , digoxin , HIV medication ( antiretrovirals ) , * Immunosuppressants e.g . cyclosporine , methadone , OCP , Statins e.g . simvastatin , warfarin ( Henderson 2002 ; Izzo 2004 ) . However interaction base case study theoretical interaction regard induced hyperforin ( constituent St. John 's wort ) ; low nonstandardised hyperforin preparation regard induce drug interaction little induction Pglycoprotein CYP P450 enzymes occurs ( Madabushi et al . 2006 ) . Although vitro study confirm kava isolate kavalactones modulate certain CYP 450 enzyme , document evidence human kavadrug pharmacokinetic interaction exists ( Mathews , Etheridge &amp; Black 2002 ; Singh 2005 ) Seeing psychologist counsellor currently previous month . NonEnglish speaker . Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2008</verification_date>
	<keyword>Plant , medicine</keyword>
	<keyword>Psychiatry</keyword>
	<keyword>Major depressive disorder</keyword>
	<keyword>Anxiety</keyword>
	<keyword>Major Depressive Disorder comorbid anxiety</keyword>
</DOC>